Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Gimatecan

EU orphan designation number: EU/3/03/174   
Active ingredient: Gimatecan
Indication: Treatment of glioma
Sponsor: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A
Viale Shakespeare 47, 00144 Roma, Italia

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
03/12/2003 Orphan designation EMEA/OD/055/03 (2003)4603 of 01/12/2003
30/11/2005 Transfer of orphan designation EMEA/OD/055/03/T/01 (2005)4724 of 28/11/2005
28/05/2009 Transfer of orphan designation EMEA/OD/055/03/T/02 (2009)4225 of 26/05/2009